SCHEMBL464600

SCHEMBL464600

c1ccc2c(OCC3CO3)c3ccccc3cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.53
ALDH1A1 P00352 4/20 0.51
TP53 P04637 3/20 0.51
TSHR P16473 3/20 0.51
HIF1A Q16665 2/20 0.51
CYP3A4 P08684 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GLA P06280 1/20 0.49
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GPR84 Q9NQS5 1/20 0.41
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
PKM P14618 2/20 0.39
CYP1A2 P05177 1/20 0.39
PPARG P37231 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612244 0.89 ALDH1A1 (0.53) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL23271790 0.89 ALDH1A1 (0.47) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL31120494 0.87 ALDH1A1 (0.51) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL8840940 0.87 ALDH1A1 (0.51) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL1715058 0.87 TDP1 (0.62) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL23271845 0.86 ALDH1A1 (0.41) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL15954516 0.86 TDP1 (0.46) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL19612250 0.86 TDP1 (0.46) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL3956570 0.85 ALDH1A1 (0.47) TDP1ALDH1A1TP53TSHRHIF1A
SCHEMBL27905802 0.85 TDP1 (0.45) TDP1ALDH1A1TP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024053402-A1 GLYCIDYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT AND MULTILAYER BODY DIC株式会社 2024-03-14 WO disclosed
WO-2023223924-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE DIC株式会社 2023-11-23 WO disclosed
US-20230333470-A1 CHEMICAL-RESISTANT PROTECTIVE FILM NISSAN CHEMICAL CORPORATION (JP) 2023-10-19 US disclosed
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 CN disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
CN-110891980-A Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2020-03-17 CN disclosed
US-20170334166-A1 BARRIER LAMINATE, GAS BARRIER FILM, AND DEVICE EMPLOYING THE SAME FUJIFILM CORPORATION (JP) 2017-11-23 US disclosed
US-20170334166-A1 BARRIER LAMINATE, GAS BARRIER FILM, AND DEVICE EMPLOYING THE SAME FUJIFILM CORPORATION (JP) 2017-11-23 US disclosed
US-20140166105-A1 BARRIER LAMINATE, GAS BARRIER FILM, AND DEVICE EMPLOYING THE SAME FUJIFILM CORPORATION (JP) 2014-06-19 US disclosed
JP-2011219515-A PHOTOPOLYMERIZATION SENSITIZER HAVING PHOTOCATIONIC POLYMERIZABILITY KAWASAKI KASEI CHEM LTD 2011-11-04 JP disclosed
EP-0369194-B1 SULFONIUM SALTS AND USE AND PREPARATION THEREOF International Business Machines Corporation (US) 1993-07-14 EP disclosed
US-5102772-A Photocurable epoxy composition with sulfonium salt photoinitiator IBM (US) 1992-04-07 US disclosed
US-5047568-A Sulfonium salts and use and preparation thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1991-09-10 US disclosed
EP-0369194-A2 Sulfonium salts and use and preparation thereof International Business Machines Corporation (US) 1990-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC TDP1 4412/4885ALDH1A1 1023/4885TP53 4149/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC TDP1 4412/4885ALDH1A1 1023/4885TP53 4149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.